ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Fighting Heartburn and Gerd Naturally – And Safely!

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Natural Bladder Control, Go Less and Live More

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Trimming the spare tire: Canola oil may cut belly fat

How Pomegranate May Protect Against Cancer

Omega Fix for Obesity: How the Right Fats Fight Fat

Curcumin Reverses the Cellular Damage of Chronic Stress

Probiotics improve cognition in Alzheimer's patients

The Onion: Cancer Fighter and Food Preserver

 
Print Page
Email Article

Pregabalin Improves Pain and Fatigue Symptoms in Patients With Fibromyalgia

  [ 559 votes ]   [ Discuss This Article ]
www.ProHealth.com • February 10, 2003


By Emma Hitt, Ph.D.

Pregabalin appears to be effective and safe in treating patients with fibromyalgia, according to new clinical trial findings. It may also appear to improve sleep quality, fatigue, and increase quality of life, research suggests. Leslie Crofford, M.D., from the University of Michigan, Ann Arbor, and colleagues presented their findings here Tuesday at the American College of Rheumatology (ACR) 66th Annual Scientific Meeting.

Patients with fibromyalgia experience chronic musculoskeletal pain, fatigue, and sleep disturbances. "There are no approved therapies, and treatments that are used often do not provide adequate relief, " Dr. Crofford and colleagues note.

According to Dr. Crofford, the mechanism of action of pregabalin is "not completely understood," but it binds to calcium channels, modulating calcium influx, which results in analgesic, anxiolytic, and anticonvulsant activity.
In a study sponsored by Pfizer, Inc., researchers evaluated the efficacy and safety of pregabalin up to 450 mg/day (150 mg three times daily) for reducing pain and associated symptoms in patients with fibromyalgia.

A total of 529 patients were randomized to receive 150, 300, or 450 mg/day of pregabalin or placebo during the second of six required visits.

Compared with those receiving placebo, patients treated with pregabalin 450 mg/day showed significant improvement in their endpoint mean pain score (-0.93; P<.001), and they were more likely to experience a 50% reduction in pain from baseline (P=.003), the researchers report.

Patients receiving 300 and 450 mg/day pregabalin also experienced reduced fatigue and improved sleep quality compared with those receiving 150 mg/day pregabalin or placebo.

Forty-eight patients (9%) withdrew due to adverse events, and 44 patients (8%) withdrew due to lack of efficacy. The most common adverse events were dizziness and somnolence, the authors note.

"Treatments for fibromyalgia are limited," Dr. Crofford told Medscape, "and pregabalin represents another treatment option compared to tricyclic antidepressants and serotonin reuptake inhibitors, which have also been shown to be useful in smaller studies," she said.

According to Dr. Crofford, within the next year, an application will be filed for approval for neuropathic pain and anxiety indications in the U.S. and in Europe, and "then there will have to be other studies with respect to fibromyalgia," she said.

"This is a very important study with robust results over a long follow-up," session moderator Laurence Bradley, PhD, from the University of Alabama, Birmingham, told Medscape. "Most of the studies for fibromyalgia pain have produced very modest results," he added.

Also presented at the session were three studies on the efficacy and safety of cyclobenzaprine, tizanidine, and methylphenidate in patients with fibromyalgia. Another study suggested that multinutrient supplementation had no effect on fibromyalgia symptoms.

ACR 66th Annual Meeting: Abstract 1653. Presented Oct. 29, 2002.

Source: Medscape. Reviewed by Gary D. Vogin, MD



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10 Ubiquinol - A More Advanced Form of the Energy Producing Nutrient CoQ-10
When a Negative is Positive - Goodnighties Recovery Sleepwear When a Negative is Positive - Goodnighties Recovery Sleepwear
Secret Nutrient for Radiant Skin Secret Nutrient for Radiant Skin
Sleep Like a Baby in Nature's Cradle Sleep Like a Baby in Nature's Cradle
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map